Pedro A. Piedra, MD

Professor
Baylor College of Medicine

Disclosure(s): Gilead: Honoraria; GSK: Grant/Research Support; Icosavax: Grant/Research Support; Merck: Advisor/Consultant, Grant/Research Support; Moderna: Advisor/Consultant; Novavax: Grant/Research Support; Pfizer: Advisor/Consultant; Sanofi-Pasteur: Advisor/Consultant, Grant/Research Support; Shionogi: Advisor/Consultant, Grant/Research Support

Poster(s):

• (P-637) Underlying Medical Conditions in Children 8 to <20 Months of Age Hospitalized with Respiratory Syncytial Virus
  Monday, October 20, 2025

  12:15 PM - 1:30 PM US ET

• (P-1782) Evolutionary Dynamics of Respiratory Syncytial Virus in Pre-pandemic, Pandemic, and Post-pandemic Periods in Houston, Texas, USA
  Wednesday, October 22, 2025

  12:15 PM - 1:30 PM US ET